
CGRP-Directed Migraine Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type
Description
CGRP-Directed Migraine Treatment Market Review 2025OverviewThe calcitonin gene-related peptide (CGRP) directed migraine treatment market has witnessed tremendous growth in recent years, propelled by a notable rise in the prevalence of migraine disorders and increased investments in therapeutic innovation. CGRP monoclonal antibodies have emerged as a cornerstone in migraine treatment due to their high efficacy and targeted mechanisms of action. As per the latest statistics, migraines affect nearly 1 billion people globally, underscoring the significance of effective treatment options in the market.Market SizeThe CGRP-directed migraine treatment market was valued at approximately USD 1.2 billion in 2020 and is anticipated to reach around USD 6.5 billion by 2030, showcasing a CAGR of about 30% during the forecast period. The growth can be attributed to the sustained demand for effective migraine treatments, the introduction of new products, and the expanding acceptance of CGRP inhibitors among healthcare professionals and patients alike.Market Share & Trends Analysis ReportThe market is categorized primarily by product type, key players, processes, applications, end-use demographics, and regions. By Product Type1. **Galcanezumab**: This CGRP inhibitor has established a significant presence in the market, accounting for roughly 21% of the total market share in 2020. It has demonstrated substantial clinical efficacy in chronic migraine prevention.2. **Erenumab**: Holding approximately 35% market share, this medication's inclusion in treatment regimens has led to enhanced patient outcomes, solidifying its place as a leader in the CGRP segment.3. **Fremanezumab**: With an 18% market share, this product continues to gain traction due to its unique dosing schedule and positive clinical trial results.4. **Eptinezumab**: This injectable formulation, with a 10% share, is designed for rapid migraine prevention, increasing its appeal among users.5. **Ubrogepant and Rimegepant**: Both oral treatments are rapidly growing alternatives, collectively capturing about 11% of the market.6. **Others**: Other new entrants and pipelines in development currently represent around 5% of the market share.By Key PlayersEli Lilly and Amgen/Novartis are among the market leaders, accounting for more than 50% of the total market share due to their extensive product portfolios and robust marketing strategies. Other noteworthy competitors include:- Teva Pharmaceutical Industries- Lundbeck- Allergan- Biohaven PharmaceuticalsThese companies are heavily investing in R&D and strategic partnerships to launch new products and enhance existing offerings.By ProcessThe CGRP treatment landscape is characterized by both preventive and acute treatment approaches. Preventive therapies, including monoclonal antibodies, dominate the market, accounting for about 75% of overall revenues, while acute therapies account for the remainder. By ApplicationThe market finds demand across various applications, primarily segmented into chronic and episodic migraine treatments. Chronic migraine applications represent the largest share, capturing around 62% of the market, driven by the increasing diagnosis and awareness of chronic migraine conditions.By End-UseThe end-use analysis reveals a strong reliance on hospitals and specialty clinics, which collectively contribute over 70% to the market. Patients also increasingly access CGRP treatments through retail pharmacies as awareness grows.By RegionThe North American region dominates the CGRP-directed migraine treatment market, holding approximately 45% market share. This is followed by Europe (about 30%), where rising healthcare spending and emphasis on neuropharmacological therapies contribute to growth. The Asia-Pacific region is projected to experience the fastest growth, with an anticipated CAGR of over 35% during the forecast period, primarily driven by improvements in healthcare infrastructure and increasing awareness among patients. Market News on Policy and CompaniesRecent regulations and healthcare policies have been increasingly supportive of innovative therapies, facilitating faster approvals through priority review processes. This momentum has propelled companies like Eli Lilly and Amgen/Novartis to expedite clinical trials and market entry of new drugs. Moreover, growing investments in telehealth services have improved access to migraine treatments, further accelerating market growth.Additionally, partnerships and collaborations within pharmaceutical sectors are envisioned to enhance research capabilities, drive product development, and enter new markets. For instance, Biohaven's strategic collaborations aim to bolster their pipeline of migraine solutions.Segment Forecasts 2025 - 2030Looking ahead, the CGRP-directed migraine treatment market is set to demonstrate vibrant expansion. - The cumulative annual growth rate is projected at 27% through 2025-2030.- By 2025, it is expected that CGRP drugs will account for over 75% of the overall migraine treatment market as more patients gain access to effective therapies.- The Asia-Pacific region will see a CAGR soaring between 40%-45%, as increasing investments in healthcare infrastructure and R&D foster a conducive environment for growth.In conclusion, the CGRP-directed migraine treatment market is on an impressive upward trajectory, propelled by growing prevalence, advancement in treatment methods, and a dynamic competitive landscape across key players and geographical regions. As neuroscience progresses and the demand for innovative therapies continues to rise, this market promises significant opportunity for stakeholders through 2030 and beyond, making it an exciting area of investment and development in the pharmaceutical industry.
Table of Contents
90 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Cgrp-Directed Migraine Treatment Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Cgrp-Directed Migraine Treatment Market in North America (2020-2030)
- 8.1 Cgrp-Directed Migraine Treatment Market Size
- 8.2 Cgrp-Directed Migraine Treatment Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Cgrp-Directed Migraine Treatment Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Cgrp-Directed Migraine Treatment Market in South America (2020-2030)
- 9.1 Cgrp-Directed Migraine Treatment Market Size
- 9.2 Cgrp-Directed Migraine Treatment Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Cgrp-Directed Migraine Treatment Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Cgrp-Directed Migraine Treatment Market in Asia & Pacific (2020-2030)
- 10.1 Cgrp-Directed Migraine Treatment Market Size
- 10.2 Cgrp-Directed Migraine Treatment Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Cgrp-Directed Migraine Treatment Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Cgrp-Directed Migraine Treatment Market in Europe (2020-2030)
- 11.1 Cgrp-Directed Migraine Treatment Market Size
- 11.2 Cgrp-Directed Migraine Treatment Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Cgrp-Directed Migraine Treatment Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Cgrp-Directed Migraine Treatment Market in MEA (2020-2030)
- 12.1 Cgrp-Directed Migraine Treatment Market Size
- 12.2 Cgrp-Directed Migraine Treatment Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Cgrp-Directed Migraine Treatment Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Cgrp-Directed Migraine Treatment Market (2020-2025)
- 13.1 Cgrp-Directed Migraine Treatment Market Size
- 13.2 Cgrp-Directed Migraine Treatment Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Cgrp-Directed Migraine Treatment Market Size by Type
- Chapter 14 Global Cgrp-Directed Migraine Treatment Market Forecast (2025-2030)
- 14.1 Cgrp-Directed Migraine Treatment Market Size Forecast
- 14.2 Cgrp-Directed Migraine Treatment Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Cgrp-Directed Migraine Treatment Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Eli Lilly
- 15.1.1 Company Profile
- 15.1.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.1.3 SWOT Analysis of Eli Lilly
- 15.1.4 Eli Lilly CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 Amgen/Novartis
- 15.2.1 Company Profile
- 15.2.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.2.3 SWOT Analysis of Amgen/Novartis
- 15.2.4 Amgen/Novartis CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 Teva
- 15.3.1 Company Profile
- 15.3.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.3.3 SWOT Analysis of Teva
- 15.3.4 Teva CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Lundbeck
- 15.4.1 Company Profile
- 15.4.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.4.3 SWOT Analysis of Lundbeck
- 15.4.4 Lundbeck CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 Allergan
- 15.5.1 Company Profile
- 15.5.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.5.3 SWOT Analysis of Allergan
- 15.5.4 Allergan CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- 15.6 Biohaven
- 15.6.1 Company Profile
- 15.6.2 Main Business and CGRP-Directed Migraine Treatment Information
- 15.6.3 SWOT Analysis of Biohaven
- 15.6.4 Biohaven CGRP-Directed Migraine Treatment Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Cgrp-Directed Migraine Treatment Report
- Table Data Sources of Cgrp-Directed Migraine Treatment Report
- Table Major Assumptions of Cgrp-Directed Migraine Treatment Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Cgrp-Directed Migraine Treatment Picture
- Table Cgrp-Directed Migraine Treatment Classification
- Table Cgrp-Directed Migraine Treatment Applications
- Table Drivers of Cgrp-Directed Migraine Treatment Market
- Table Restraints of Cgrp-Directed Migraine Treatment Market
- Table Opportunities of Cgrp-Directed Migraine Treatment Market
- Table Threats of Cgrp-Directed Migraine Treatment Market
- Table Covid-19 Impact For Cgrp-Directed Migraine Treatment Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Cgrp-Directed Migraine Treatment
- Table Cost Structure Analysis of Cgrp-Directed Migraine Treatment
- Table Key End Users
- Table Latest News of Cgrp-Directed Migraine Treatment Market
- Table Merger and Acquisition
- Table Planned/Future Project of Cgrp-Directed Migraine Treatment Market
- Table Policy of Cgrp-Directed Migraine Treatment Market
- Table 2020-2030 North America Cgrp-Directed Migraine Treatment Market Size
- Figure 2020-2030 North America Cgrp-Directed Migraine Treatment Market Size and CAGR
- Table 2020-2030 North America Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 North America Cgrp-Directed Migraine Treatment Key Players Revenue
- Table 2020-2025 North America Cgrp-Directed Migraine Treatment Key Players Market Share
- Table 2020-2030 North America Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2030 United States Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Canada Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Mexico Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 South America Cgrp-Directed Migraine Treatment Market Size
- Figure 2020-2030 South America Cgrp-Directed Migraine Treatment Market Size and CAGR
- Table 2020-2030 South America Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 South America Cgrp-Directed Migraine Treatment Key Players Revenue
- Table 2020-2025 South America Cgrp-Directed Migraine Treatment Key Players Market Share
- Table 2020-2030 South America Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2030 Brazil Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Argentina Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Chile Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Peru Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size
- Figure 2020-2030 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size and CAGR
- Table 2020-2030 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 Asia & Pacific Cgrp-Directed Migraine Treatment Key Players Revenue
- Table 2020-2025 Asia & Pacific Cgrp-Directed Migraine Treatment Key Players Market Share
- Table 2020-2030 Asia & Pacific Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2030 China Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 India Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Japan Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 South Korea Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Southeast Asia Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Australia Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Europe Cgrp-Directed Migraine Treatment Market Size
- Figure 2020-2030 Europe Cgrp-Directed Migraine Treatment Market Size and CAGR
- Table 2020-2030 Europe Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 Europe Cgrp-Directed Migraine Treatment Key Players Revenue
- Table 2020-2025 Europe Cgrp-Directed Migraine Treatment Key Players Market Share
- Table 2020-2030 Europe Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2030 Germany Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 France Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 United Kingdom Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Italy Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Spain Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Belgium Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Netherlands Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Austria Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Poland Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Russia Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 MEA Cgrp-Directed Migraine Treatment Market Size
- Figure 2020-2030 MEA Cgrp-Directed Migraine Treatment Market Size and CAGR
- Table 2020-2030 MEA Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 MEA Cgrp-Directed Migraine Treatment Key Players Revenue
- Table 2020-2025 MEA Cgrp-Directed Migraine Treatment Key Players Market Share
- Table 2020-2030 MEA Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2030 Egypt Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Israel Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 South Africa Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2030 Turkey Cgrp-Directed Migraine Treatment Market Size
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Size by Region
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Size Share by Region
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Share by Application
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Key Vendors Revenue
- Figure 2020-2025 Global Cgrp-Directed Migraine Treatment Market Size and Growth Rate
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Key Vendors Market Share
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2020-2025 Global Cgrp-Directed Migraine Treatment Market Share by Type
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Market Size by Region
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Market Size Share by Region
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Market Size by Application
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Market Share by Application
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Key Vendors Revenue
- Figure 2025-2030 Global Cgrp-Directed Migraine Treatment Market Size and Growth Rate
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Key Vendors Market Share
- Table 2025-2030 Global Cgrp-Directed Migraine Treatment Market Size by Type
- Table 2025-2030 Cgrp-Directed Migraine Treatment Global Market Share by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.